Rossiiskii immunologicheskii zhurnalIssue 4Membrane-bound Heat Shock Protein HSP70 as a Target for Theranostics of Tumors
views: 1153
Readers community rating: votes 0
1. Shevtsov M., Multhoff G. Heat shock protein-peptide and HSP-based immunotherapies for the treatment of cancer. Front Immunol. 2016, 7, 171.
2. Multhoff G. Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods. 2007, 43, 229–237.
3. Shevtsov M. A., Multhoff G. Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor. Current Drug Metabolism. 2016, 17(8), 737–744.
4. Shevtsov M. A., Nikolaev B. P., Ryzhov V. A., Yakovleva L. Y., Marchenko Y. Y., Parr M. A., Rolich V. I., Mikhrina A. L., Dobrodumov A. V., Pitkin E., Multhoff G. Ionizing radiation improves glioma-specifi c targeting of superparamagnetic iron oxide nanoparticles conjugated with cmHsp70.1 antibodies (SPION-cmHsp70.1). Nanoscale. 2015, 7(48), 20652–20664.
